Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2018

Share-based Payment Arrangement [Abstract]

Schedule of Fair Value Assumptions

The assumptions used for valuing the 2017 SARs included the following:

Assumptions	2017 SARs
Market closing price of the Common Stock	$	7.37
Exercise price	$	7.37
Risk-free interest rate	2.1		%
Estimated price volatility	58.5		%
Expected term	6.00 years
Dividend yield	—		%

The assumptions used for valuing the 2018 SARs included the following:

Assumptions	2018 SARs
Market closing price of the Common Stock	$	7.92
Exercise price	$	7.92
Risk-free interest rate	2.6		%
Estimated price volatility	78.5		%
Expected term	6.58 years
Dividend yield	—		%

Schedule of SAR Activity

activity consisted of the following:

Number of Shares under SARs	Shares		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016	152,600		$	16.55	9.02	$	—
Granted	5,000		7.37			—
Exercised	—		—			—
Forfeited	(67,130	)	23.16			—
Expired	(6,750	)	12.68			—
Outstanding at December 31, 2017	83,720		11.02		8.21	1
Exercisable at December 31, 2017	39,360		$	11.25	8.15	$	—

Number of Shares under SARs	Shares		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2017	83,720		$	11.02	8.21	$	1
Granted	60,000		7.92			—
Exercised	—		—			—
Forfeited	(1,000	)	11.25			—
Expired	(4,700	)	11.25			—
Outstanding at December 31, 2018	138,020		9.66		8.05	89
Exercisable at December 31, 2018	87,370		$	11.14	6.21	$	5

Schedule of Restricted Stock Activity

Restricted stock activity consisted of the following:

	Shares		Weighted-Average Grant Date Fair Value
December 31, 2016	104,340		$	41.61
Granted	437,472		8.13
Forfeited	(29,144	)	38.33
Vested	(16,395	)	44.19
December 31, 2017	496,273		$	12.20
Granted	50,000		10.92
Forfeited	(32,547	)	25.95
Vested	(254,440	)	10.14
Balance as of December 31, 2018	259,286		$	12.25